Europe — EMA
Octanate Lv (Human Coagulation Factor Viii)
Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a coagulation factor replacement presented as a solution for injection for intravenous use.
Request sourcing
What is Human Coagulation Factor Viii?
Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a coagulation factor replacement presented as a solution for injection for intravenous use. It treats hemophilia A by providing the missing clotting protein in patients with this inherited disorder. GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Coagulation Factor Viii used for?
Octanate Lv is used in the management of bleeding disorders that involve the intrinsic coagulation pathway, particularly hemophilia A. - Hemophilia A: Provides the missing factor VIII to control and prevent bleeding episodes. - Surgical prophylaxis in hemophilia A patients: Maintains adequate factor levels during operative procedures. - Acute bleeding episodes in hemophilia A: Restores clotting ability to stop ongoing bleeding.
